Research programme: G-protein coupled receptor modulators - Ono Pharmaceutical
Latest Information Update: 07 Oct 2015
At a glance
- Originator Ono Pharmaceutical
- Class Proteins; Small molecules
- Mechanism of Action G protein-coupled receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Unspecified